{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-054782","form_type":"8-K","ticker":"NMTC","cik":"0001500198","company_name":"NEUROONE MEDICAL TECHNOLOGIES Corp","filed_at":"2024-06-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.693981+00:00","generated_at":"2026-06-01T02:48:58.788297+00:00","sec_items":["3.03","5.03","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"NeuroOne amends bylaws: reduces stockholder quorum to one-third, updates proxy rules","bullets":["Stockholder quorum reduced from majority to one-third of outstanding voting power.","New universal proxy compliance requirement under SEC Rule 14a-19 for director nominations.","Enhanced disclosure obligations for stockholder nominations and proposals, including derivative interests.","Special meeting nominators must hold 10% of voting power and be stockholder at notice and record dates.","Clarified personal jurisdiction and service of process for foreign actions."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-054782","json":"https://secwatch.observer/filing/0001213900-24-054782.json","markdown":"https://secwatch.observer/filing/0001213900-24-054782.md","text":"https://secwatch.observer/filing/0001213900-24-054782.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1500198/000121390024054782/0001213900-24-054782-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1500198/000121390024054782/ea0208217-8k_neuro.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T02:48:58.788297+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}